Bb Biotech as of Sept. 30, 2018
Portfolio Holdings for Bb Biotech
Bb Biotech holds 32 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 11.8 | $447M | 8.7M | 51.58 | |
Neurocrine Biosciences (NBIX) | 10.3 | $388M | 3.2M | 122.95 | |
Celgene Corporation | 7.1 | $267M | 3.0M | 89.49 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 7.0 | $264M | 1.4M | 192.74 | |
Incyte Corporation (INCY) | 7.0 | $263M | 3.8M | 69.08 | |
Alexion Pharmaceuticals | 4.8 | $183M | 1.3M | 139.01 | |
Agios Pharmaceuticals (AGIO) | 4.5 | $170M | 2.2M | 77.12 | |
Sage Therapeutics (SAGE) | 4.0 | $151M | 1.1M | 141.25 | |
Gilead Sciences (GILD) | 4.0 | $151M | 2.0M | 77.21 | |
Halozyme Therapeutics (HALO) | 4.0 | $150M | 8.2M | 18.17 | |
Esperion Therapeutics (ESPR) | 3.9 | $146M | 3.3M | 44.37 | |
Alnylam Pharmaceuticals (ALNY) | 3.2 | $120M | 1.4M | 87.52 | |
Radius Health | 3.1 | $117M | 6.6M | 17.80 | |
Tesaro | 3.0 | $114M | 2.9M | 39.01 | |
Myovant Sciences | 2.5 | $95M | 3.6M | 26.55 | |
Akcea Therapeutics Inc equities | 2.2 | $84M | 2.4M | 35.02 | |
Regeneron Pharmaceuticals (REGN) | 2.1 | $81M | 200k | 404.04 | |
Wave Life Sciences (WVE) | 1.8 | $69M | 1.4M | 50.00 | |
Intercept Pharmaceuticals In | 1.8 | $69M | 546k | 126.36 | |
Macrogenics (MGNX) | 1.7 | $64M | 3.0M | 21.44 | |
Argenx Se (ARGX) | 1.5 | $56M | 735k | 75.84 | |
Voyager Therapeutics (VYGR) | 1.4 | $53M | 2.8M | 18.92 | |
Nektar Therapeutics (NKTR) | 1.4 | $52M | 845k | 60.96 | |
Exelixis (EXEL) | 1.3 | $49M | 2.8M | 17.72 | |
Intra Cellular Therapies (ITCI) | 1.3 | $48M | 2.2M | 21.70 | |
Alder Biopharmaceuticals | 1.0 | $38M | 2.3M | 16.65 | |
Myokardia | 0.9 | $33M | 510k | 65.20 | |
G1 Therapeutics (GTHX) | 0.6 | $22M | 425k | 52.29 | |
Novavax | 0.4 | $16M | 8.3M | 1.88 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.3 | $10M | 2.3M | 4.40 | |
Scholar Rock Hldg Corp (SRRK) | 0.1 | $4.9M | 190k | 25.75 | |
Achillion Pharmaceuticals | 0.1 | $4.7M | 1.3M | 3.68 |